These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6978332)

  • 21. Beta-lactamase stability and inhibitory activity of meropenem combined with a potent antibacterial activity.
    Nouda H; Harabe ET; Sumita Y; Okuda T; Fukasawa M
    Chemotherapy; 1992; 38(4):218-24. PubMed ID: 1473360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Imipenem-Relebactam and Meropenem-Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations.
    Zhanel GG; Lawrence CK; Adam H; Schweizer F; Zelenitsky S; Zhanel M; Lagacé-Wiens PRS; Walkty A; Denisuik A; Golden A; Gin AS; Hoban DJ; Lynch JP; Karlowsky JA
    Drugs; 2018 Jan; 78(1):65-98. PubMed ID: 29230684
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activity of beta-lactamases against beta-lactams.
    Stratton CW
    J Antimicrob Chemother; 1988 Jul; 22 Suppl A():23-35. PubMed ID: 3062002
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of analytical isoelectric focusing for detection and identification of beta-lactamases.
    Mathew A; Harris AM; Marshall MJ; Ross GW
    J Gen Microbiol; 1975 May; 88(1):169-78. PubMed ID: 807678
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A simple method for testing the efficacy of a beta-lactamase inhibitor against beta-lactamase-producing gram-negative bacteria.
    Sawai T; Yoshida T
    J Antibiot (Tokyo); 1982 Aug; 35(8):1072-7. PubMed ID: 6982888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cefotetan and beta-lactamases. II. An unusual property: the inactivation of some beta-lactamases by cefotetan.
    Labia R; Morand A; Peduzzi J
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():153-7. PubMed ID: 6601655
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Susceptibility of clinical isolates to expanded-spectrum beta-lactams alone and in the presence of beta-lactamase inhibitors.
    Qadri SM; Ueno Y; Cunha BA
    Chemotherapy; 1996; 42(5):334-42. PubMed ID: 8874972
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A study of the beta-lactamases of 100 clinical isolates of Yersinia enterocolitica.
    Pham JN; Bell SM; Lanzarone JY
    J Antimicrob Chemother; 1991 Jul; 28(1):19-24. PubMed ID: 1769940
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro evaluation of SF-2103A, a novel carbapenem antibiotic, as a beta-lactamase inhibitor.
    Niwa T; Yoshida T; Tamura A; Kazuno Y; Inouye S; Ito T; Kojima M
    J Antibiot (Tokyo); 1986 Jul; 39(7):943-55. PubMed ID: 3019978
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The β-Lactams Strike Back: Ceftazidime-Avibactam.
    Zasowski EJ; Rybak JM; Rybak MJ
    Pharmacotherapy; 2015 Aug; 35(8):755-70. PubMed ID: 26289307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Real-time activity assays of β-lactamases in living bacterial cells: application to the inhibition of antibiotic-resistant E. coli strains.
    Ge Y; Zhou YJ; Yang KW; Zhang YL; Xiang Y; Zhang YJ
    Mol Biosyst; 2017 Oct; 13(11):2323-2327. PubMed ID: 28906528
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Designing of inhibitors against CTX-M-15 type β-lactamase: potential drug candidate against β-lactamases-producing multi-drug-resistant bacteria.
    Ali A; Danishuddin ; Maryam L; Srivastava G; Sharma A; Khan AU
    J Biomol Struct Dyn; 2018 May; 36(7):1806-1821. PubMed ID: 28545327
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of beta-lactamases in clinical isolates of Bacteroides.
    Eley A; Greenwood D
    J Antimicrob Chemother; 1986 Sep; 18(3):325-33. PubMed ID: 3490466
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Mechanisms of bacterial resistance to beta-lactams by beta-lactamases].
    Sawai T
    Nihon Rinsho; 1997 May; 55(5):1225-30. PubMed ID: 9155179
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Meeting the challenges of beta-lactamases.
    Moellering RC
    J Antimicrob Chemother; 1993 Jan; 31 Suppl A():1-8. PubMed ID: 8449834
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The inhibition of beta-lactamases from gram-negative bacteria by clavulanic acid.
    Reading C; Farmer T
    Biochem J; 1981 Dec; 199(3):779-87. PubMed ID: 7041890
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical isolates of Escherichia coli producing TRI beta-lactamases: novel TEM-enzymes conferring resistance to beta-lactamase inhibitors.
    Vedel G; Belaaouaj A; Gilly L; Labia R; Philippon A; Névot P; Paul G
    J Antimicrob Chemother; 1992 Oct; 30(4):449-62. PubMed ID: 1490918
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Branhamella catarrhalis: antibiotic sensitivities and beta-lactamases.
    Stobberingh EE; Davies BI; van Boven CP
    J Antimicrob Chemother; 1984 Jan; 13(1):55-64. PubMed ID: 6607919
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Development of New Small-Molecule Inhibitors Targeting Bacterial Metallo-β-lactamases.
    Wang P; Cheng J; Liu CC; Tang K; Xu F; Yu Z; Yu B; Chang J
    Curr Top Med Chem; 2018; 18(10):834-843. PubMed ID: 29773066
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interactions of meropenem, with beta-lactamases, including enzymes with extended-spectrum activity against third-generation cephalosporins.
    Labia R; Morand A; Tiwari K; Sirot D; Chanal C
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():219-23. PubMed ID: 2808209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.